Our resource hub is home to a wealth of articles, stories and videos about managing and living with type 1 diabetes.
Place your order for our free information packs that support adults and children who have been recently diagnosed.
Our researchers are working on different ways to develop a cure for type 1 diabetes - from growing insulin-producing beta cells in labs to hacking the immune system.
Learn about the technologies that can deliver insulin automatically when needed. And discover the next generation of insulins that are currently being developed.
You could win a cash prize of up to £25,000 when you play the Breakthrough T1D lottery. As well as the chance to win great prizes, you’ll also help fund our research to find a cure for type 1 diabetes.
Invite your friends, family, colleagues or clients to an exceptional black-tie event in the heart of London. Every ticket, every bid, every moment helps us move closer to a cure.
Our ambitious new roadmap is aimed at driving significant advancements in type 1 diabetes research, treatment, and care.
Join the type 1 diabetes community and come together, raising awareness and vital funds for T1D.
We provide a wealth of information and free resources to help you support and empower your patients or students.
Take our free course for schools to learn more about supporting pupils with type 1 diabetes in educational settings.
JDRF has now rebranded to Breakthrough T1D. Our name has changed, our mission has not.
Home > News & events > News > JDRF funds small pilot projects exploring promising diabetes research ideas
We are delighted to announce the recipients of our latest Small Grant Awards: Dr Joanne Boldison, Dr Fiona Docherty and Dr Nicholas Thomas. These three UK-based researchers are all focusing on different areas of type 1 diabetes, from preventing its onset to replacing insulin-producing cells in people who already have it.
The JDRF UK Small Grant Awards are small sums of money given to early career researchers in the UK to get their research started. Awarded each year, these grants offer funding of up to £25,000 to any project focused on type 1 diabetes. As the money available is less than our larger grants, the awards often give early career researchers an opportunity to get funding when they otherwise might not.
Joanne’s research project will investigate immune cells called B-cells – not to be confused with insulin-producing beta cells. These immune cells could be involved in the development of type 1 diabetes. Joanne will try to understand more about B-cells and their role in type 1 to see if they could be targeted by potential treatments for type 1.
Fiona will try to grow insulin-producing beta cells in her lab that can release more insulin than the beta cells currently being used in a clinical trial in the US. She will turn stem cells – cells that can grow into any other cell type – into beta cells and activate a gene that she knows controls insulin production at different stages in the beta cells’ development. Fiona hopes to create high functioning beta cells, which could one day be used in clinical trials to treat type 1 diabetes.
Nick’s project will follow-up 850 people who were diagnosed with type 1 or 2 diabetes three years ago. They have all done a C-peptide test to see how much insulin their bodies can still release, which can help confirm whether someone has type 1 or type 2 diabetes. Nick will use this test along with questionnaires to find out whether these people’s diagnosis and/or treatment changed due to their C-peptide levels. This research aims to ensure everyone with diabetes is given the right diagnosis, treatment, technologies and education.
All our Small Grant Awards offer funding for one year. After the projects end, the researchers will then need to analyse their results and produce a paper about their research. If their projects are successful, the researchers are also likely to apply for more funding to scale up their research.
New data from Sana Biotechnology, in collaboration with Uppsala University Hospital in Sweden, shows that six months post-transplant, one person with type 1 diabetes (T1D) is successfully producing insulin and does not require immunosuppression.
US-based company Vertex have published promising figures from their cell therapy trial, showing advancements in stem cell research.
We're calling for urgent reform as new report reveals older people with T1D are systematically failed by health and social care services.
Breakthrough T1D has helped organise an event hosted by Tomislav Sokol titled ‘Accelerating Breakthroughs to Address Unmet Needs in Type 1 Diabetes.’
Don’t miss out on the latest research, inspiring stories, tech news, upcoming events, and handy information on living well with type 1. Join us now and receive it all straight to your inbox.
It’s thanks to your dedication that we have funded great progress in type 1 cure, treatment and prevention research. Help us to continue our vital research.
